2017
DOI: 10.5606/kbbihtisas.2017.63004
|View full text |Cite
|
Sign up to set email alerts
|

An unusual sinonasal inverted papilloma originating from superior turbinate and extending to epiglottis

Abstract: Sinonasal inverted papillomas are benign tumors of the nasal cavity and paranasal sinuses. The basic characteristics of these papillomas are their different localizations in the nasal cavity, local aggressive behavior and potential to transform into malignant tumors. The most common symptoms of those tumors are nasal obstruction, rhinorrhea, and epistaxis. Rare symptoms such as dysphagia and hoarseness may be seen in relation with the localization and the size of the tumor. In this article, we present an unusu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 9 publications
(19 reference statements)
0
1
0
Order By: Relevance
“…Therefore, computed tomography (CT) scan of the facial bones has long been considered the criterion standard exam for primary diagnosis and follow-up [ 2 ]. Due to its invasiveness, its high degree of recurrence, and a possibility of malignant transformation [ 3 ], its treatment consists of radical surgery [ 4 ]. Although immunomodulatory therapies have increasingly emerged as a promising new treatment option for advanced malignancies, results from clinical studies of immune checkpoint modulating drugs in this setting have led to mixed results [ 5 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, computed tomography (CT) scan of the facial bones has long been considered the criterion standard exam for primary diagnosis and follow-up [ 2 ]. Due to its invasiveness, its high degree of recurrence, and a possibility of malignant transformation [ 3 ], its treatment consists of radical surgery [ 4 ]. Although immunomodulatory therapies have increasingly emerged as a promising new treatment option for advanced malignancies, results from clinical studies of immune checkpoint modulating drugs in this setting have led to mixed results [ 5 8 ].…”
Section: Introductionmentioning
confidence: 99%